Jim Simons’s ReShape Lifesciences Inc. Common Stock RSLS Stock Holding History

Jim Simons’s Portfolio RSLS Stock Details RSLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-16,341	Closed	-$101K	–	3774
2018 Q3	$101K	Buy	+16,341	New	+$1.41M	﹤0.01%	3241

Other funds holding RSLS

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Jim Simons's RSLS Position: Q4 2018 in Review

Jim Simons sold out of ReShape Lifesciences Inc. Common Stock (RSLS) in Q4 2018, closing a stake of 16,341 shares — an estimated $101K sold.

Jim Simons first reported a position in RSLS in Q3 2018 and held it in 1 quarter. The position peaked at $101K in Q3 2018. 2 funds tracked by Wall St. Rank hold RSLS as of Q4 2018.

Jim Simons reported no remaining ReShape Lifesciences Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Jim Simons sold 16,341 ReShape Lifesciences Inc. Common Stock shares in Q4 2018, an estimated $101K.
Jim Simons first reported a position in ReShape Lifesciences Inc. Common Stock in Q3 2018 and held it in 1 quarter.
Jim Simons's ReShape Lifesciences Inc. Common Stock position peaked at $101K in Q3 2018.
2 funds tracked by Wall St. Rank held ReShape Lifesciences Inc. Common Stock as of Q4 2018.

Based on Renaissance Technologies's 13F filing for Q4 2018, filed 13 Feb 2019.